ENPP2 and non-small cell lung carcinoma: Because data sets with RNA profiling of large numbers of patients for ICB-treated NSCLC are not readily available, we used a published melanoma data set taken from paired pretreatment and on-treatment biopsy samples, where patients received nivolumab and response data are available (34), to correlate ENPP2 expression with immunotherapy treatment response.